Abstract
Drugs that are poorly soluble in water present a major challenge to the pharmaceutical industry because they tend to show poor oral bioavailability. To overcome this problem, much attention has been given to delivering drugs in formulations that supersaturate in the gastrointestinal (GI) fluids. One approach to achieve the supersaturation is to formulate drugs in amorphous forms. This chapter considers amorphous forms of the pure active pharmaceutical ingredients (APIs), also known as neat amorphous APIs. The relationship between supersaturation and absorption is discussed, along with the thermodynamics of solubility of supersaturated solutions. The relevant properties of neat amorphous APIs are discussed and explained in terms of thermodynamics and microscopic models, and their relationships to improved solubility/dissolution and physical stability are considered. In addition, the relationship between neat amorphous forms and glasses, especially as presented in the literature, is reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamson AW, Gast AP (1997) Physical chemistry of surfaces, 6th edn. Wiley, New York
Adjei A, Newburger J, Martin A (1980) Extended Hildebrand approach: solubility of caffeine in dioxane-water mixtures. J Pharm Sci 69:659–661
Amidon GL, Lennernäs H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–420
Angell CA (1995) Formation of glasses from liquids and biopolymers. Science 267:1924–1935
Atkins PW (1998) Physical chemistry, 6th edn. Freeman, New York
Bellantone RA, Patel P, Sandhu H, Choi D, Singhal D, Chokshi H, Malick AW, Shah NH (2012) A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis. J Pharm Sci 101:4549–4558
Burger A, Ramberger R (1979) On the polymorphism of pharmaceutical and other molecular crystals I. Theory of thermodynamic rules. Mikrochimica Acta 11:259–281
Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281–1302
D’Arcy DM, Persoons T (2011) Mechanistic modelling and mechanistic monitoring: simulation and shadowgraph imaging of particulate dissolution in the flow-through apparatus. J Pharm Sci 100:1102–1115
Donth E (2001) The glass transition: relaxation dynamics in liquids and disordered materials. Springer, Berlin
Garca-Coln LS, del Castillo LF, Goldstein P (1989) Theoretical basis for the Vogel-Fulcher-Tammann equation. Phys Rev B 40:7040–7044
Gavezzotti A (2007) Molecular aggregation: structure analysis and molecular simulation of crystals and liquids. Oxford University Press, New York (Chap. 14)
Hancock BC, Zografi G (1997) Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1–12
Hancock BC, Shamblin SL, Zografi G (1995) Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res 12:799–806
Herschler B, Humer C (2012) FDA new drug approvals hit 16-year high in 2012. Reuters Online. 2012. http://www.reuters.com/article/2012/12/31/us-pharmaceuticals-fda-approvals-idUSBRE8BU0EK20121231. Accessed 31 Dec 2012
Hildebrand J, Scott R (1950) Solubility of non-electrolytes, 3rd edn. Rheinhold, New York
Hill TL (1986) An introduction to statistical thermodynamics. Dover, New York
House JE (2007) Principles of chemical kinetics, 2nd edn. Elsevier, Amsterdam
Khawam A, Flanagan DR (2006) Basics and applications of solid state kinetics: a pharmaceutical perspective. J Pharm Sci 95:472–498
Kittel C (1986) Introduction to solid state physics, 6th edn. Wiley, New York
Klotz IM, Rosenberg RM (1974) Chemical thermodynamics—basic theory and methods, 3rd edn. Benjamin-Cummings, New York
Klug HP, Alexander LE (1974) X-ray diffraction procedures for polycrystalline and amorphous materials. Wiley, New York
Leuner C, Dressman J (2002) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47–60
Martin A, Swarbrick J, Cammarata A (1983) Physical pharmacy, 3rd edn. Lea & Febiger, Philadelphia
Mauro JC, Yue Y, Ellison AJ, Gupta PK, Allan DC (2009) Viscosity of glass-forming liquids. Proc Natl Acad Sci 106:19780–19784
Mullin JW (2001) Crystallization, 4th edn. Butterworth-Heinemann, Boston
Simonelli AP, Mehta SC, Higuchi WI (1969) Dissolution rates of high energy polyvinyl pyrrolidone (PVP)-sulfathiazole coprecipitates. J Pharm Sci 58:538–549
Trachenko K (2008) The Vogel–Fulcher–Tammann law in the elastic theory of glass transition. J Non-cryst Solids 354:3903–3906
Williams RO III, Watts AB, Miller DA (eds) (2012) Formulating poorly water soluble drugs. Springer, New York (Preface)
Yu L (2001) Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Del Rev 48:27–42
Acknowledgments
I would like to thank Drs. Navnit Shah, Harpreet Sandhu, and Duk Soon Choi for their invaluable interactions over the past several years. I would also like to especially thank Drs. Kosha Shah and Piyush Patel, with whom I have had countless scientific conversations and who have kept me on track when I was overwhelmed with commitments.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Controlled Release Society
About this chapter
Cite this chapter
Bellantone, R. (2014). Fundamentals of Amorphous Systems: Thermodynamic Aspects. In: Shah, N., Sandhu, H., Choi, D., Chokshi, H., Malick, A. (eds) Amorphous Solid Dispersions. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1598-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1598-9_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1597-2
Online ISBN: 978-1-4939-1598-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)